REVIEW OF DICLOFENAC AND EVALUATION OF ITS PLACE IN THERAPY AS A NONSTEROIDAL ANTIINFLAMMATORY AGENT

被引：107

作者：

SKOUTAKIS, VA

CARTER, CA

MICKLE, TR

SMITH, VH

ARKIN, CR

ALISSANDRATOS, J

PETTY, DE

机构：

[1] UNIV TENNESSEE,COLL PHARM,KNOXVILLE,TN 37996

[2] VET ADM MED CTR,MEMPHIS,TN 38104

[3] BAPTIST MEM HOSP,MEMPHIS,TN 38146

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1988年 / 22卷 / 11期

关键词：

D O I：

10.1177/106002808802201102

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：850 / 859

页数：10

共 104 条

[91] BIOTRANSFORMATION OF DICLOFENAC SODIUM (VOLTAREN) IN ANIMALS AND IN MAN .1. ISOLATION AND IDENTIFICATION OF PRINCIPAL METABOLITES [J].

STIERLIN, H ;

FAIGLE, JW ;

SALLMANN, A ;

KUNG, W ;

RICHTER, WJ ;

KRIEMLER, HP ;

ALT, KO ;

WINKLER, T .

XENOBIOTICA, 1979, 9 (10) :601-610

[92] ASTHMATIC ATTACKS INDUCED IN ASPIRIN-SENSITIVE PATIENTS BY DICLOFENAC AND NAPROXEN [J].

SZCZEKLIK, A ;

GRYGLEWSKI, RJ ;

CZERNIAWSKAMYSIK, G ;

PIETON, R .

BRITISH MEDICAL JOURNAL, 1977, 2 (6081) :231-232

[93]

TANNENBAUM H, 1984, CURR THER RES CLIN E, V35, P357

[94]

TORRALBA TP, 1976, PHILIPPINE J INTERNA, V14, P77

[95]

TREADWELL BLJ, 1979, NEW ZEAL MED J, V89, P43

[96]

USOBIAGA JLM, 1976, GACETA MED ESPANOLA, V50, P282

[97]

VALTONEN EJ, 1978, SCAND J RHEUMATO S22, V22, P69

[98]

VOGT KH, 1976, THERAPIEWOCHE, V26, P2975

[99]

WAGENHAUSER FJ, 1975, SCHWEIZ MED WSCHR, V105, P652

[100]

WILKENS RF, 1985, SEMIN ARTHRITIS R S1, V15, P105

← 2 3 4 5 6 7 8 9 10 11 →